"Health Promoting Effects of the Microalgae Phaeodactylum Tricornutum"
NCT ID: NCT04288544
Last Updated: 2021-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2020-02-25
2020-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The microalgae PT is rich in omega-3 FS eicosapentaenoic acid (EPA), which is otherwise found mainly in fatty fish, and could therefore be an alternative or vegetarian source of polyunsaturated fatty acids.
Previous work by U. Neumann has shown that the microalgae P. tricornutum could be used for human nutrition. No toxic effects could be observed in vivo and the bioavailability of fatty acids and proteins could also be successfully demonstrated. In vitro experiments also showed a more anti-inflammatory, anti-oxidative and anti-proliferative effect on human blood cells. For this reason, a health-promoting effect is also possible in human nutrition, but this must be proven in human studies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental: Intervention group
The patients get 1x 5,3g per day the microalgae Phaeodactylum tricornutumover for two weeks.
Omega-3-fatty acid capsule
Open, monocentric intervention study in crossover design
sea fish
Open, monocentric intervention study in crossover design
Omega-3 capsules
The patients get one capsule per day of the Omega-3-fatty acid capsules for 2 weeks.
Microalgae
Open, monocentric intervention study in crossover design
sea fish
Open, monocentric intervention study in crossover design
sea fish (facultative)
as positive control, one portion of fish is eaten per week for 2 weeks after the Intervention of 8 weeks and 2 wash out (omega 3 must not be eaten).
Microalgae
Open, monocentric intervention study in crossover design
Omega-3-fatty acid capsule
Open, monocentric intervention study in crossover design
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microalgae
Open, monocentric intervention study in crossover design
Omega-3-fatty acid capsule
Open, monocentric intervention study in crossover design
sea fish
Open, monocentric intervention study in crossover design
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willingness to follow the prescribed diet for the duration of the study
* No participation in another clinical trial (current or within the last 30 days)
Exclusion Criteria
* Pregnancy/nursing period
* Relevant violations of the food protocol
* Occurrence of relevant diseases (if necessary, individual case decision)
* Revocation of consent
* Accommodation in a clinic or similar institution due to official or court order
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Hohenheim
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephan C. Bischoff, MD, Professor
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
lena Stiefvatter
Stuttgart, , Germany
University of Hohenheim
Stuttgart, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UHohenheim
Identifier Type: -
Identifier Source: org_study_id